EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term effects of abomasal infusion of linoleic and linolenic acids on the enrichment of n-6 and n-3 fatty acids into plasma lipid fractions of lactating cows

J M Dos Santos Neto, L C Worden, J P Boerman, C M Bradley, A L Lock

Journal of Dairy Science · 2024

DOI: 10.3168/jds.2024-24907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Dairy Science, 2024. Verfasst von J M Dos Santos Neto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, Michigan State University, East Lansing, MI 48824. Hauptthemen laut MEDLINE: Lactation, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Abomasum. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michigan State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our objective was to compare abomasal infusions of linoleic (18:2n-6) and α-linolenic (18:3n-3) acids on the enrichment of n-6 and n-3 fatty acids (FA) into the plasma lipid fractions of lactating dairy cows and evaluate their potential carryover effects in plasma lipid fractions postinfusion. Six rumen-cannulated multiparous Holstein cows (252 ± 33 DIM) were fed the same diet and assigned to 1 of 2 treatments in a completely randomized design with repeated measures. Treatments were abomasal infusions (67 g/d total FA) of (1) n-6 FA blend (N6) to provide approximately 43 g/d 18:2n-6 and 8 g/d of 18:3n-3 or (2) n-3 FA blend (N3) providing 43 g/d 18:3n-3 and 8 g/d 18:2n-6. Treatments were dissolved in ethanol, and the daily dose for each treatment was divided into 4 equal infusions, occurring every 6 h. The treatment period lasted from d 1 to 20, and the carryover period lasted from d 21 to 40. Results are presented as FA contents within each of the 4 main plasma lipid fractions: cholesterol esters (CE), phospholipids (PL); triglycerides, and plasma nonesterified fatty acids. Concentrations of individual lipid fractions in plasma were not quantified. Plasma CE and PL had the highest content of PUFA during both the treatment and carryover periods. In plasma PL, N3 increased the contents of total n-3 FA (134%), 18:3n-3 (267%), and eicosapentaenoic acid (96.3%, 20:5n-3), and decreased total n-6 FA (8.14%) and 18:2n-6 (8.16%) from d 4 to 20 compared with N6. In plasma CE, N3 increased the contents of total n-3 FA (191%) from d 4 to 20, 18:3n-3 from d 2 to 20 (178%), and 20:5n-3 from d 6 to 20 (59.9%), while N3 decreased total n-6 FA from d 4 to 20 (11.2%) and 18:2n-6 from d 2 to 20 (10.5%) compared with N6. In addition, compared with N6, N3 decreased arachidonic acid (20:4n-6) at d 2 (45%) and from d 10 to 20 (14.7%) in PL and tended to decrease 20:4n-6 without interacting with time for CE. Phospholipids were the only lipid fraction with detectable levels of docosahexaenoic acid (22:3n-6) in all samples, but we did not observe differences between treatments. In plasma trigylcerides, N3 increased the contents of total n-3 FA (135%) and 18:3n-3 (146%) from d 4 to 20, increased 20:5n-3 from d 12 to 20 (89%), decreased or tended to decrease total n-6 FA content from d 6 and 8 (26.9%), and tended to decrease 18:2n-6 at d 8 compared with N6. A similar pattern was observed for plasma nonesterified FA. We observed positive carryover effects for both N3 and N6 at different degrees in all lipid fractions, with N3 promoting more consistent outcomes and increasing total n-3 FA throughout the carryover period (from d 22 to 40) in both PL (52.8%) and CE (68.6%) compared with N6. It is important to emphasize that the higher magnitude responses observed for n-3 FA are also influenced by the content of n-3 FA being much lower than those of n-6 FA in all lipid fractions. Although these data provide important and robust information, future research quantifying changes in concentrations of individual lipid fractions in plasma and the entry and exit rates of specific FA will further enhance our understanding. In conclusion, abomasally infusing N3 and N6 increased the contents of n-3 and n-6 FA, respectively, in all plasma lipid fractions. These responses were more evident in PL and CE. We also observed positive carryover effects in all lipid fractions, where N3 had more consistent outcomes than N6. Our results indicate that dairy cows have a robust mechanism to conserve essential FA, with a pronounced preference for n-3 FA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactationFatty Acids, Omega-3Fatty Acids, Omega-6AbomasumDietAnimalsCattleFemaleLinoleic AcidLipidsLinolenic AcidsAnimal Feed

Stichwörter der Autor:innen

long-chain fatty acidsomega-3omega-6

Substanzen

Fatty Acids, Omega-3Fatty Acids, Omega-6Linoleic AcidLipidsLinolenic Acids

Autor:innen und Institutionen

  • Department of Animal Science, Michigan State University, East Lansing, MI 48824.
  • Department of Animal Science, Michigan State University, East Lansing, MI 48824. Electronic address: allock@msu.edu.

Förderung

  • Michigan State University

Zitieren

APA

Dos Santos Neto, J. M., Worden, L. C., Boerman, J. P., Bradley, C. M., & Lock, A. L. (2024). Long-term effects of abomasal infusion of linoleic and linolenic acids on the enrichment of n-6 and n-3 fatty acids into plasma lipid fractions of lactating cows. Journal of Dairy Science. https://doi.org/10.3168/jds.2024-24907

Vancouver

Dos Santos Neto JM, Worden LC, Boerman JP, Bradley CM, Lock AL. Long-term effects of abomasal infusion of linoleic and linolenic acids on the enrichment of n-6 and n-3 fatty acids into plasma lipid fractions of lactating cows. Journal of Dairy Science. 2024. doi:10.3168/jds.2024-24907

BibTeX
@article{DosSantosNeto2024,
  author = {Dos Santos Neto, J M and Worden, L C and Boerman, J P and Bradley, C M and Lock, A L},
  title = {Long-term effects of abomasal infusion of linoleic and linolenic acids on the enrichment of n-6 and n-3 fatty acids into plasma lipid fractions of lactating cows},
  journal = {Journal of Dairy Science},
  year = {2024},
  doi = {10.3168/jds.2024-24907}
}
Kostenlos starten →